SRS8388494 SAMN17573662 1451-Pt1_TIL_CD45neg_scRNAseq Pt1_TIL_CD45neg_scRNAseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt1_TIL_CD45neg_scRNAseq submitted sample id Pt1_TIL_CD45neg_scRNAseq submitted subject id Pt1 gap_sample_id 4300056 gap_subject_id 2345511 sex male body site Axillary LN histological type melanoma analyte type RNA is tumor Yes gap_consent_code 1 gap_consent_short_name GRU SRS8388495 SAMN17573660 1451-Pt1_TIL_CD45pos_CD3neg_scRNAseq Pt1_TIL_CD45pos_CD3neg_scRNAseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt1_TIL_CD45pos_CD3neg_scRNAseq submitted sample id Pt1_TIL_CD45pos_CD3neg_scRNAseq submitted subject id Pt1 gap_sample_id 4300059 gap_subject_id 2345511 sex male body site Axillary LN histological type melanoma analyte type RNA is tumor Yes gap_consent_code 1 gap_consent_short_name GRU SRS8388497 SAMN17573634 1451-Pt1_PBMC_PRE_CD45posCD3pos_scRNAseq Pt1_PBMC_PRE_CD45posCD3pos_scRNAseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt1_PBMC_PRE_CD45posCD3pos_scRNAseq submitted sample id Pt1_PBMC_PRE_CD45posCD3pos_scRNAseq submitted subject id Pt1 gap_sample_id 4300050 gap_subject_id 2345511 sex male body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388498 SAMN17573637 1451-Pt1_PBMC_POST_CD45posCD3pos_scRNAseq Pt1_PBMC_POST_CD45posCD3pos_scRNAseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt1_PBMC_POST_CD45posCD3pos_scRNAseq submitted sample id Pt1_PBMC_POST_CD45posCD3pos_scRNAseq submitted subject id Pt1 gap_sample_id 4300047 gap_subject_id 2345511 sex male body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388499 SAMN17573624 1451-Pt1_PBMC_RELAPSE_CD45posCD3pos_scRNAseq Pt1_PBMC_RELAPSE_CD45posCD3pos_scRNAseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt1_PBMC_RELAPSE_CD45posCD3pos_scRNAseq submitted sample id Pt1_PBMC_RELAPSE_CD45posCD3pos_scRNAseq submitted subject id Pt1 gap_sample_id 4300053 gap_subject_id 2345511 sex male body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388500 SAMN17573651 1451-Pt1_TIL_CD45neg_scTCRseq Pt1_TIL_CD45neg_scTCRseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt1_TIL_CD45neg_scTCRseq submitted sample id Pt1_TIL_CD45neg_scTCRseq submitted subject id Pt1 gap_sample_id 4300057 gap_subject_id 2345511 sex male body site Axillary LN histological type melanoma analyte type RNA is tumor Yes gap_consent_code 1 gap_consent_short_name GRU SRS8388501 SAMN17573654 1451-Pt1_TIL_CD45pos_CD3neg_scTCRseq Pt1_TIL_CD45pos_CD3neg_scTCRseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt1_TIL_CD45pos_CD3neg_scTCRseq submitted sample id Pt1_TIL_CD45pos_CD3neg_scTCRseq submitted subject id Pt1 gap_sample_id 4300060 gap_subject_id 2345511 sex male body site Axillary LN histological type melanoma analyte type RNA is tumor Yes gap_consent_code 1 gap_consent_short_name GRU SRS8388503 SAMN17573633 1451-Pt1_PBMC_PRE_CD45posCD3pos_scTCRseq Pt1_PBMC_PRE_CD45posCD3pos_scTCRseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt1_PBMC_PRE_CD45posCD3pos_scTCRseq submitted sample id Pt1_PBMC_PRE_CD45posCD3pos_scTCRseq submitted subject id Pt1 gap_sample_id 4300051 gap_subject_id 2345511 sex male body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388504 SAMN17573630 1451-Pt1_PBMC_POST_CD45posCD3pos_scTCRseq Pt1_PBMC_POST_CD45posCD3pos_scTCRseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt1_PBMC_POST_CD45posCD3pos_scTCRseq submitted sample id Pt1_PBMC_POST_CD45posCD3pos_scTCRseq submitted subject id Pt1 gap_sample_id 4300048 gap_subject_id 2345511 sex male body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388505 SAMN17573659 1451-Pt1_PBMC_RELAPSE_CD45posCD3pos_scTCRseq Pt1_PBMC_RELAPSE_CD45posCD3pos_scTCRseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt1_PBMC_RELAPSE_CD45posCD3pos_scTCRseq submitted sample id Pt1_PBMC_RELAPSE_CD45posCD3pos_scTCRseq submitted subject id Pt1 gap_sample_id 4300054 gap_subject_id 2345511 sex male body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388506 SAMN17573638 1451-Pt1_TIL_CD45neg_CITEseq Pt1_TIL_CD45neg_CITEseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt1_TIL_CD45neg_CITEseq submitted sample id Pt1_TIL_CD45neg_CITEseq submitted subject id Pt1 gap_sample_id 4300055 gap_subject_id 2345511 sex male body site Axillary LN histological type melanoma analyte type RNA is tumor Yes gap_consent_code 1 gap_consent_short_name GRU SRS8388507 SAMN17573635 1451-Pt1_TIL_CD45pos_CD3neg_CITEseq Pt1_TIL_CD45pos_CD3neg_CITEseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt1_TIL_CD45pos_CD3neg_CITEseq submitted sample id Pt1_TIL_CD45pos_CD3neg_CITEseq submitted subject id Pt1 gap_sample_id 4300058 gap_subject_id 2345511 sex male body site Axillary LN histological type melanoma analyte type RNA is tumor Yes gap_consent_code 1 gap_consent_short_name GRU SRS8388509 SAMN17573620 1451-Pt1_PBMC_PRE_CD45posCD3pos_CITEseq Pt1_PBMC_PRE_CD45posCD3pos_CITEseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt1_PBMC_PRE_CD45posCD3pos_CITEseq submitted sample id Pt1_PBMC_PRE_CD45posCD3pos_CITEseq submitted subject id Pt1 gap_sample_id 4300049 gap_subject_id 2345511 sex male body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388510 SAMN17573658 1451-Pt1_PBMC_POST_CD45posCD3pos_CITEseq Pt1_PBMC_POST_CD45posCD3pos_CITEseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt1_PBMC_POST_CD45posCD3pos_CITEseq submitted sample id Pt1_PBMC_POST_CD45posCD3pos_CITEseq submitted subject id Pt1 gap_sample_id 4300046 gap_subject_id 2345511 sex male body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388511 SAMN17573629 1451-Pt1_PBMC_RELAPSE_CD45posCD3pos_CITEseq Pt1_PBMC_RELAPSE_CD45posCD3pos_CITEseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt1_PBMC_RELAPSE_CD45posCD3pos_CITEseq submitted sample id Pt1_PBMC_RELAPSE_CD45posCD3pos_CITEseq submitted subject id Pt1 gap_sample_id 4300052 gap_subject_id 2345511 sex male body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388513 SAMN17573663 1451-Pt12_PBMC_PRE_CD45posCD3pos_CITEseq Pt12_PBMC_PRE_CD45posCD3pos_CITEseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt12_PBMC_PRE_CD45posCD3pos_CITEseq submitted sample id Pt12_PBMC_PRE_CD45posCD3pos_CITEseq submitted subject id Pt12 gap_sample_id 4300036 gap_subject_id 3243378 sex female body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388514 SAMN17573640 1451-Pt12_PBMC_POST_CD45posCD3pos_CITEseq Pt12_PBMC_POST_CD45posCD3pos_CITEseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt12_PBMC_POST_CD45posCD3pos_CITEseq submitted sample id Pt12_PBMC_POST_CD45posCD3pos_CITEseq submitted subject id Pt12 gap_sample_id 4300033 gap_subject_id 3243378 sex female body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388516 SAMN17573618 1451-Pt3_PBMCs_scRNAseq Pt3_PBMCs_scRNAseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt3_PBMCs_scRNAseq submitted sample id Pt3_PBMCs_scRNAseq submitted subject id Pt3 gap_sample_id 4300065 gap_subject_id 2345514 sex female body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388518 SAMN17573648 1451-Pt3_PBMCs_scTCRseq Pt3_PBMCs_scTCRseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt3_PBMCs_scTCRseq submitted sample id Pt3_PBMCs_scTCRseq submitted subject id Pt3 gap_sample_id 4300066 gap_subject_id 2345514 sex female body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388520 SAMN17573664 1451-Pt3_PBMCs_CITEseq Pt3_PBMCs_CITEseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt3_PBMCs_CITEseq submitted sample id Pt3_PBMCs_CITEseq submitted subject id Pt3 gap_sample_id 4300064 gap_subject_id 2345514 sex female body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388521 SAMN17573657 1451-Pt6pre_TIL_CD45neg_scRNAseq Pt6pre_TIL_CD45neg_scRNAseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt6pre_TIL_CD45neg_scRNAseq submitted sample id Pt6pre_TIL_CD45neg_scRNAseq submitted subject id Pt6 gap_sample_id 4300074 gap_subject_id 2345517 sex male body site Lung histological type melanoma analyte type RNA is tumor Yes gap_consent_code 1 gap_consent_short_name GRU SRS8388522 SAMN17573656 1451-Pt6pre_TIL_CD45pos_CD3neg_scRNAseq Pt6pre_TIL_CD45pos_CD3neg_scRNAseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt6pre_TIL_CD45pos_CD3neg_scRNAseq submitted sample id Pt6pre_TIL_CD45pos_CD3neg_scRNAseq submitted subject id Pt6 gap_sample_id 4300076 gap_subject_id 2345517 sex male body site Lung histological type melanoma analyte type RNA is tumor Yes gap_consent_code 1 gap_consent_short_name GRU SRS8388525 SAMN17573642 1451-Pt6_PBMC_PRE_CD45posCD3pos_scRNAseq Pt6_PBMC_PRE_CD45posCD3pos_scRNAseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt6_PBMC_PRE_CD45posCD3pos_scRNAseq submitted sample id Pt6_PBMC_PRE_CD45posCD3pos_scRNAseq submitted subject id Pt6 gap_sample_id 4300071 gap_subject_id 2345517 sex male body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388526 SAMN17573653 1451-Pt6pre_TIL_CD45pos_CD3neg_scTCRseq Pt6pre_TIL_CD45pos_CD3neg_scTCRseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt6pre_TIL_CD45pos_CD3neg_scTCRseq submitted sample id Pt6pre_TIL_CD45pos_CD3neg_scTCRseq submitted subject id Pt6 gap_sample_id 4300077 gap_subject_id 2345517 sex male body site Lung histological type melanoma analyte type RNA is tumor Yes gap_consent_code 1 gap_consent_short_name GRU SRS8388528 SAMN17573628 1451-Pt12_PBMC_PRE_CD45posCD3pos_scTCRseq Pt12_PBMC_PRE_CD45posCD3pos_scTCRseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt12_PBMC_PRE_CD45posCD3pos_scTCRseq submitted sample id Pt12_PBMC_PRE_CD45posCD3pos_scTCRseq submitted subject id Pt12 gap_sample_id 4300038 gap_subject_id 3243378 sex female body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388530 SAMN17573652 1451-Pt6_PBMC_PRE_CD45posCD3pos_scTCRseq Pt6_PBMC_PRE_CD45posCD3pos_scTCRseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt6_PBMC_PRE_CD45posCD3pos_scTCRseq submitted sample id Pt6_PBMC_PRE_CD45posCD3pos_scTCRseq submitted subject id Pt6 gap_sample_id 4300072 gap_subject_id 2345517 sex male body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388531 SAMN17573623 1451-Pt6pre_TIL_CD45neg_CITEseq Pt6pre_TIL_CD45neg_CITEseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt6pre_TIL_CD45neg_CITEseq submitted sample id Pt6pre_TIL_CD45neg_CITEseq submitted subject id Pt6 gap_sample_id 4300073 gap_subject_id 2345517 sex male body site Lung histological type melanoma analyte type RNA is tumor Yes gap_consent_code 1 gap_consent_short_name GRU SRS8388532 SAMN17573631 1451-Pt6pre_TIL_CD45pos_CD3neg_CITEseq Pt6pre_TIL_CD45pos_CD3neg_CITEseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt6pre_TIL_CD45pos_CD3neg_CITEseq submitted sample id Pt6pre_TIL_CD45pos_CD3neg_CITEseq submitted subject id Pt6 gap_sample_id 4300075 gap_subject_id 2345517 sex male body site Lung histological type melanoma analyte type RNA is tumor Yes gap_consent_code 1 gap_consent_short_name GRU SRS8388535 SAMN17573632 1451-Pt12_PBMC_POST_CD45posCD3pos_scTCRseq Pt12_PBMC_POST_CD45posCD3pos_scTCRseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt12_PBMC_POST_CD45posCD3pos_scTCRseq submitted sample id Pt12_PBMC_POST_CD45posCD3pos_scTCRseq submitted subject id Pt12 gap_sample_id 4300035 gap_subject_id 3243378 sex female body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388536 SAMN17573647 1451-Pt6_PBMC_PRE_CD45posCD3pos_CITEseq Pt6_PBMC_PRE_CD45posCD3pos_CITEseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt6_PBMC_PRE_CD45posCD3pos_CITEseq submitted sample id Pt6_PBMC_PRE_CD45posCD3pos_CITEseq submitted subject id Pt6 gap_sample_id 4300070 gap_subject_id 2345517 sex male body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388537 SAMN17573617 1451-Pt12_TIL_CD45neg_CITEseq Pt12_TIL_CD45neg_CITEseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt12_TIL_CD45neg_CITEseq submitted sample id Pt12_TIL_CD45neg_CITEseq submitted subject id Pt12 gap_sample_id 4300039 gap_subject_id 3243378 sex female body site Axillary LN histological type melanoma analyte type RNA is tumor Yes gap_consent_code 1 gap_consent_short_name GRU SRS8388538 SAMN17573644 1451-Pt12_TIL_CD45pos_CD3neg_CITEseq Pt12_TIL_CD45pos_CD3neg_CITEseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt12_TIL_CD45pos_CD3neg_CITEseq submitted sample id Pt12_TIL_CD45pos_CD3neg_CITEseq submitted subject id Pt12 gap_sample_id 4300041 gap_subject_id 3243378 sex female body site Axillary LN histological type melanoma analyte type RNA is tumor Yes gap_consent_code 1 gap_consent_short_name GRU SRS8388540 SAMN17573645 1451-Pt12_PBMC_PRE_CD45posCD3pos_scRNAseq Pt12_PBMC_PRE_CD45posCD3pos_scRNAseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt12_PBMC_PRE_CD45posCD3pos_scRNAseq submitted sample id Pt12_PBMC_PRE_CD45posCD3pos_scRNAseq submitted subject id Pt12 gap_sample_id 4300037 gap_subject_id 3243378 sex female body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388541 SAMN17573616 1451-Pt12_PBMC_POST_CD45posCD3pos_scRNAseq Pt12_PBMC_POST_CD45posCD3pos_scRNAseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt12_PBMC_POST_CD45posCD3pos_scRNAseq submitted sample id Pt12_PBMC_POST_CD45posCD3pos_scRNAseq submitted subject id Pt12 gap_sample_id 4300034 gap_subject_id 3243378 sex female body site blood histological type PBMC analyte type RNA is tumor No gap_consent_code 1 gap_consent_short_name GRU SRS8388542 SAMN17573619 1451-Pt12_TIL_CD45neg_scRNAseq Pt12_TIL_CD45neg_scRNAseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt12_TIL_CD45neg_scRNAseq submitted sample id Pt12_TIL_CD45neg_scRNAseq submitted subject id Pt12 gap_sample_id 4300040 gap_subject_id 3243378 sex female body site Axillary LN histological type melanoma analyte type RNA is tumor Yes gap_consent_code 1 gap_consent_short_name GRU SRS8388543 SAMN17573636 1451-Pt12_TIL_CD45pos_CD3neg_scRNAseq Pt12_TIL_CD45pos_CD3neg_scRNAseq 9606 Homo sapiens gap_accession phs001451 submitter handle NCI_PersonalNeoantigenCancerVaccines biospecimen repository NCI_PersonalNeoantigenCancerVaccines study name A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma study design Clinical Trial biospecimen repository sample id Pt12_TIL_CD45pos_CD3neg_scRNAseq submitted sample id Pt12_TIL_CD45pos_CD3neg_scRNAseq submitted subject id Pt12 gap_sample_id 4300042 gap_subject_id 3243378 sex female body site Axillary LN histological type melanoma analyte type RNA is tumor Yes gap_consent_code 1 gap_consent_short_name GRU